
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10457914
[patent_doc_number] => 20150342929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'Mixed ORL1/mu-agonists for the Treatment of Pain'
[patent_app_type] => utility
[patent_app_number] => 14/732451
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 17702
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732451 | Mixed ORL1/mu-agonists for the Treatment of Pain | Jun 4, 2015 | Abandoned |
Array
(
[id] => 12790471
[patent_doc_number] => 20180155326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => METHOD FOR PREPARING TRITYL CANDESARTAN
[patent_app_type] => utility
[patent_app_number] => 15/578541
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578541 | METHOD FOR PREPARING TRITYL CANDESARTAN | Jun 4, 2015 | Abandoned |
Array
(
[id] => 11755924
[patent_doc_number] => 20170202791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/313877
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5529
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313877 | N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | May 28, 2015 | Abandoned |
Array
(
[id] => 11283654
[patent_doc_number] => 09499497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'
[patent_app_type] => utility
[patent_app_number] => 14/722413
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23361
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722413
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722413 | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase | May 26, 2015 | Issued |
Array
(
[id] => 16970471
[patent_doc_number] => 11066432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Ether phospholipids and method for producing the same
[patent_app_type] => utility
[patent_app_number] => 15/533528
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 5762
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533528 | Ether phospholipids and method for producing the same | May 12, 2015 | Issued |
Array
(
[id] => 10362859
[patent_doc_number] => 20150247863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS'
[patent_app_type] => utility
[patent_app_number] => 14/709886
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26148
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709886 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | May 11, 2015 | Abandoned |
Array
(
[id] => 11834553
[patent_doc_number] => 20170216273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Nicotine Derivatives and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/357071
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8424
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357071
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357071 | Nicotine Derivatives and Methods of Use | May 10, 2015 | Abandoned |
Array
(
[id] => 10437010
[patent_doc_number] => 20150322022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'THERAPEUTIC CATECHOLS'
[patent_app_type] => utility
[patent_app_number] => 14/709108
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9773
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709108
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709108 | Therapeutic catechols | May 10, 2015 | Issued |
Array
(
[id] => 11471195
[patent_doc_number] => 20170057978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/308058
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26399
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308058
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308058 | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | May 7, 2015 | Issued |
Array
(
[id] => 11487013
[patent_doc_number] => 09593078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Crystal forms'
[patent_app_type] => utility
[patent_app_number] => 14/707433
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19810
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707433 | Crystal forms | May 7, 2015 | Issued |
Array
(
[id] => 11935086
[patent_doc_number] => 20170239235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'SMALL-MOLECULE UT-A-SELECTIVE UREA TRANSPORT INIHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/310061
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310061 | SMALL-MOLECULE UT-A-SELECTIVE UREA TRANSPORT INIHIBITORS | May 7, 2015 | Abandoned |
Array
(
[id] => 14294285
[patent_doc_number] => 10287257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Linker molecule for multiplex recognition by atomic force microscopy (AFM)
[patent_app_type] => utility
[patent_app_number] => 15/308517
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3687
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308517 | Linker molecule for multiplex recognition by atomic force microscopy (AFM) | May 6, 2015 | Issued |
Array
(
[id] => 12085928
[patent_doc_number] => 09839642
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/309533
[patent_app_country] => US
[patent_app_date] => 2015-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82694
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309533
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309533 | Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors | May 3, 2015 | Issued |
Array
(
[id] => 14055403
[patent_doc_number] => 10231978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Anordrin compositions and methods for treating diseases
[patent_app_type] => utility
[patent_app_number] => 15/309426
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24329
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309426 | Anordrin compositions and methods for treating diseases | Apr 29, 2015 | Issued |
Array
(
[id] => 11457033
[patent_doc_number] => 20170050939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/305809
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9940
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305809 | SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES | Apr 20, 2015 | Abandoned |
Array
(
[id] => 11434690
[patent_doc_number] => 20170035711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'PARASITE CONTROL AGENT FOR PARASITICIDE'
[patent_app_type] => utility
[patent_app_number] => 15/304144
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15498
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304144
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304144 | PARASITE CONTROL AGENT FOR PARASITICIDE | Apr 19, 2015 | Abandoned |
Array
(
[id] => 10474763
[patent_doc_number] => 20150359780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'Compositions for Improved Body Composition'
[patent_app_type] => utility
[patent_app_number] => 14/689806
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3890
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689806
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/689806 | Compositions for Improved Body Composition | Apr 16, 2015 | Abandoned |
Array
(
[id] => 11296680
[patent_doc_number] => 09504672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Compositions and methods for treating or preventing pneumovirus infection and associated diseases'
[patent_app_type] => utility
[patent_app_number] => 14/683935
[patent_app_country] => US
[patent_app_date] => 2015-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 18010
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14683935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/683935 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases | Apr 9, 2015 | Issued |
Array
(
[id] => 10515926
[patent_doc_number] => 09242963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 14/677260
[patent_app_country] => US
[patent_app_date] => 2015-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81542
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14677260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/677260 | Organic compounds | Apr 1, 2015 | Issued |
Array
(
[id] => 10380607
[patent_doc_number] => 20150265613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME'
[patent_app_type] => utility
[patent_app_number] => 14/671030
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 48751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671030
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671030 | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME | Mar 26, 2015 | Abandoned |